Carregant...
Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
Development of noninvasive treatments for erythroplasia of Queyrat, a carcinoma in situ, is expected. This case suggests topical imiquimod might be a candidate with regimens consisting of much longer duration of the treatment than for genital warts and the maintenance phase of the treatment course t...
Guardat en:
| Publicat a: | Clin Case Rep |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452465/ https://ncbi.nlm.nih.gov/pubmed/30997072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2076 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|